学术探索
学术期刊
新闻热点
数据分析
智能评审

CLINICAL PHARMACOKINETICS OF CHOLINESTERASE-INHIBITORS

被引：78
作者：
AQUILONIUS, SM [1 ]
HARTVIG, P [1 ]
机构：
[1] UNIV HOSP UPPSALA,HOSP PHARM,S-75185 UPPSALA,SWEDEN
来源：
CLINICAL PHARMACOKINETICS | 1986年 / 11卷 / 03期
关键词：
D O I：
10.2165/00003088-198611030-00005
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：236 / 249
页数：14
相关论文
共 79 条
[1]  
Aeschlimann JA, 1931, J PHARMACOL EXP THER, V43, P413
[2]  
ALBANUS L, 1970, FOA REPORTS, V4, P3
[3]   SYSTEMIC SIDE-EFFECTS WITH EYE DROPS [J].
ALEXANDER, WD .
BRITISH MEDICAL JOURNAL, 1981, 282 (6273) :1359-1359
[4]  
ALRIDGE WN, 1981, ACTA PHARM TOXICO S5, V49, P3
[5]   PHARMACOKINETICS AND ORAL BIOAVAILABILITY OF PYRIDOSTIGMINE IN MAN [J].
AQUILONIUS, SM ;
ECKERNAS, SA ;
HARTVIG, P ;
LINDSTROM, B ;
OSTERMAN, PO .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 18 (05) :423-428
[6]   CLINICAL-PHARMACOLOGY OF PYRIDOSTIGMINE AND NEOSTIGMINE IN PATIENTS WITH MYASTHENIA-GRAVIS [J].
AQUILONIUS, SM ;
ECKERNAS, SA ;
HARTVIG, P ;
LINDSTROM, B ;
OSTERMAN, PO ;
STALBERG, E .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1983, 46 (10) :929-935
[7]   USE OF PHYSOSTIGMINE AS AN ANTIDOTE IN TRICYCLIC ANTI-DEPRESSANT INTOXICATION [J].
AQUILONIUS, SM ;
HEDSTRAND, U .
ACTA ANAESTHESIOLOGICA SCANDINAVICA, 1978, 22 (01) :40-45
[8]   CHOLINERGIC AND DOPAMINERGIC MECHANISMS IN HUNTINGTONS CHOREA [J].
AQUILONIUS, SM ;
SJOSTROM, R .
LIFE SCIENCE PART 1 PHYSIOLOGY & PHARMACOLOGY, 1971, 10 (07) :405-+
[9]  
AQUILONIUS SM, 1978, ACTA NEUROL SCAND, V57, P271
[10]   PHARMACOKINETIC STUDY OF NEOSTIGMINE IN MAN USING GAS CHROMATOGRAPHY-MASS SPECTROMETRY [J].
AQUILONIUS, SM ;
ECKERNAS, SA ;
HARTVIG, P ;
HULTMAN, J ;
LINDSTROM, B ;
OSTERMAN, PO .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 15 (05) :367-371
12345678